Surgical management of cervical cancer: A Society of Gynecologic Oncology evidence-based review
In brief
Guidance favors simple hysterectomy for low-risk early cervical cancer
For low-risk stage IA through IB1 cervical cancer, the review prefers simple hysterectomy with lymph node assessment; selected patients seeking fertility preservation can have conization or simple trachelectomy. It also favors sentinel node biopsy under an accepted algorithm and open surgery when radical hysterectomy is needed, but evidence quality varies and some recommendations rely on expert consensus.
- Journal
- Gynecologic oncology (Q1)
- Published
- 10 November 2026
- Study design
- Narrative review / expert opinion
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- A Melamed, A L Covens, K S Pfaendler, J Nakayama, E K Hill, S Isani, et al.
- PMID
- 43008586
- DOI
- 10.1016/j.ygyno.2026.10.034
Why clinicians should know about it
- Picked for Surgical Oncology (paper of the day, 13 November 2026): Evidence-based guidance on resection extent and nodal de-escalation
Abstract
Surgical management of cervical cancer has changed substantially over the past decade as randomized and prospective data have refined the extent of resection, the role of fertility-sparing surgery, nodal assessment strategies, and the choice of surgical approach. This Society of Gynecologic Oncology evidence-based review addresses the upfront surgical management of cervical cancer. Surgery for recurrent disease, including pelvic exenteration and resection of oligometastatic recurrence, is outside its scope. A panel of gynecologic oncologists and subject matter experts identified twelve clinical questions spanning extent of resection, fertility-sparing surgery, lymph node assessment, surgical approach, and the integration of surgery with chemoradiation. Relevant literature was systematically collected and synthesized, and each recommendation was assigned a strength of recommendation and quality of evidence using a two-part rating system adapted from the ASCCP guidelines. Recommendations were approved by the SGO Clinical Practice Committee, Document Review Panel, and Board of Directors. Simple hysterectomy with nodal assessment is preferred for low-risk FIGO 2018 stage IA through IB1 disease. Fertility-sparing surgery is acceptable for appropriately selected patients with low-risk stage IA1 through IB1 tumors, with conization or simple trachelectomy preferred over radical trachelectomy. Sentinel lymph node biopsy may replace complete pelvic lymphadenectomy when an accepted algorithm is applied, with indocyanine green and near-infrared imaging the preferred mapping technique. When radical hysterectomy is indicated, the open approach is preferred outside of a clinical trial. Neoadjuvant chemotherapy followed by surgery is not recommended in place of chemoradiation, and hysterectomy after completion of definitive chemoradiation is not recommended in the absence of documented residual disease. Evidence quality varies considerably across questions, and several recommendations rest on observational data or expert consensus.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.